APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oseltamivir Phosphate Antiviral Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oseltamivir Phosphate Antiviral Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchOseltamivir Phosphate Antiviral Drug Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Oseltamivir Phosphate Antiviral Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Oseltamivir Phosphate Antiviral Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oseltamivir Phosphate Antiviral Drug Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Oseltamivir Phosphate Antiviral Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Oseltamivir Phosphate Antiviral Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oseltamivir Phosphate Antiviral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oseltamivir Phosphate Antiviral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oseltamivir Phosphate Antiviral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oseltamivir Phosphate Antiviral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oseltamivir Phosphate Antiviral Drug include Teva Pharmaceuticals, SL Pharmaceutica, Cspc Holdings, Roche Group, Kelun Pharmaceutical, HEC ChangJiang Pharmaceutical, BrightGene Bio-Medical Technology, Zydus Cadila and Strides Pharma Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oseltamivir Phosphate Antiviral Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oseltamivir Phosphate Antiviral Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oseltamivir Phosphate Antiviral Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oseltamivir Phosphate Antiviral Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Oseltamivir Phosphate Antiviral Drug Segment by Company

Teva Pharmaceuticals

SL Pharmaceutica

Cspc Holdings

Roche Group

Kelun Pharmaceutical

HEC ChangJiang Pharmaceutical

BrightGene Bio-Medical Technology

Zydus Cadila

Strides Pharma Inc.

Novadoz

Natco Pharma

Macleods Pharmaceuticals

LUPINE Limited

Hetero Group

Camber Pharmaceuticals

Amneal Pharmaceuticals

Alvogen

Alembic Pharmaceuticals

Ajanta Pharma

Oseltamivir Phosphate Antiviral Drug Segment by Type

Capsule

Suspension

Oseltamivir Phosphate Antiviral Drug Segment by Application

Child

Aldult

Oseltamivir Phosphate Antiviral Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oseltamivir Phosphate Antiviral Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oseltamivir Phosphate Antiviral Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oseltamivir Phosphate Antiviral Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oseltamivir Phosphate Antiviral Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oseltamivir Phosphate Antiviral Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oseltamivir Phosphate Antiviral Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oseltamivir Phosphate Antiviral Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oseltamivir Phosphate Antiviral Drug Industry Trends Table 2. Oseltamivir Phosphate Antiviral Drug Industry Drivers Table 3. Oseltamivir Phosphate Antiviral Drug Industry Opportunities and Challenges Table 4. Oseltamivir Phosphate Antiviral Drug Industry Restraints Table 5. Global Oseltamivir Phosphate Antiviral Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oseltamivir Phosphate Antiviral Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Manufacturers Table 9. Global Oseltamivir Phosphate Antiviral Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Oseltamivir Phosphate Antiviral Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oseltamivir Phosphate Antiviral Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oseltamivir Phosphate Antiviral Drug Manufacturers, Product Type & Application Table 13. Global Oseltamivir Phosphate Antiviral Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oseltamivir Phosphate Antiviral Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Capsule Table 17. Major Manufacturers of Suspension Table 18. Global Oseltamivir Phosphate Antiviral Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (k units) Table 20. Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2027-2032) & (k units) Table 21. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Type (2021-2026) Table 22. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Type (2027-2032) Table 23. Global Oseltamivir Phosphate Antiviral Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021-2026) & (k units) Table 25. Global Oseltamivir Phosphate Antiviral Drug Revenue by Type (2027-2032) & (k units) Table 26. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Type (2021-2026) Table 27. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Child Table 29. Major Manufacturers of Aldult Table 30. Global Oseltamivir Phosphate Antiviral Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (k units) Table 32. Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2027-2032) & (k units) Table 33. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Application (2021-2026) Table 34. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Application (2027-2032) Table 35. Global Oseltamivir Phosphate Antiviral Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021-2026) & (k units) Table 37. Global Oseltamivir Phosphate Antiviral Drug Revenue by Application (2027-2032) & (k units) Table 38. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Application (2021-2026) Table 39. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Application (2027-2032) Table 40. Global Oseltamivir Phosphate Antiviral Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2021-2026) & (k units) Table 42. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Region (2021-2026) Table 43. Global Oseltamivir Phosphate Antiviral Drug Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Oseltamivir Phosphate Antiviral Drug Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Oseltamivir Phosphate Antiviral Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026) & (k units) Table 47. North America Oseltamivir Phosphate Antiviral Drug Sales by Country (2027-2032) & (k units) Table 48. Europe Oseltamivir Phosphate Antiviral Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026) & (k units) Table 50. Europe Oseltamivir Phosphate Antiviral Drug Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Oseltamivir Phosphate Antiviral Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Oseltamivir Phosphate Antiviral Drug Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales by Country (2027-2032) & (k units) Table 57. Global Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Oseltamivir Phosphate Antiviral Drug Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Oseltamivir Phosphate Antiviral Drug Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Region (2021-2026) Table 61. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Region (2027-2032) Table 62. Teva Pharmaceuticals Company Information Table 63. Teva Pharmaceuticals Business Overview Table 64. Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 66. Teva Pharmaceuticals Recent Development Table 67. SL Pharmaceutica Company Information Table 68. SL Pharmaceutica Business Overview Table 69. SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 71. SL Pharmaceutica Recent Development Table 72. Cspc Holdings Company Information Table 73. Cspc Holdings Business Overview Table 74. Cspc Holdings Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Cspc Holdings Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 76. Cspc Holdings Recent Development Table 77. Roche Group Company Information Table 78. Roche Group Business Overview Table 79. Roche Group Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Roche Group Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 81. Roche Group Recent Development Table 82. Kelun Pharmaceutical Company Information Table 83. Kelun Pharmaceutical Business Overview Table 84. Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 86. Kelun Pharmaceutical Recent Development Table 87. HEC ChangJiang Pharmaceutical Company Information Table 88. HEC ChangJiang Pharmaceutical Business Overview Table 89. HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 91. HEC ChangJiang Pharmaceutical Recent Development Table 92. BrightGene Bio-Medical Technology Company Information Table 93. BrightGene Bio-Medical Technology Business Overview Table 94. BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 96. BrightGene Bio-Medical Technology Recent Development Table 97. Zydus Cadila Company Information Table 98. Zydus Cadila Business Overview Table 99. Zydus Cadila Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Zydus Cadila Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 101. Zydus Cadila Recent Development Table 102. Strides Pharma Inc. Company Information Table 103. Strides Pharma Inc. Business Overview Table 104. Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 106. Strides Pharma Inc. Recent Development Table 107. Novadoz Company Information Table 108. Novadoz Business Overview Table 109. Novadoz Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Novadoz Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 111. Novadoz Recent Development Table 112. Natco Pharma Company Information Table 113. Natco Pharma Business Overview Table 114. Natco Pharma Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Natco Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 116. Natco Pharma Recent Development Table 117. Macleods Pharmaceuticals Company Information Table 118. Macleods Pharmaceuticals Business Overview Table 119. Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 121. Macleods Pharmaceuticals Recent Development Table 122. LUPINE Limited Company Information Table 123. LUPINE Limited Business Overview Table 124. LUPINE Limited Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. LUPINE Limited Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 126. LUPINE Limited Recent Development Table 127. Hetero Group Company Information Table 128. Hetero Group Business Overview Table 129. Hetero Group Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Hetero Group Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 131. Hetero Group Recent Development Table 132. Camber Pharmaceuticals Company Information Table 133. Camber Pharmaceuticals Business Overview Table 134. Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 136. Camber Pharmaceuticals Recent Development Table 137. Amneal Pharmaceuticals Company Information Table 138. Amneal Pharmaceuticals Business Overview Table 139. Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 141. Amneal Pharmaceuticals Recent Development Table 142. Alvogen Company Information Table 143. Alvogen Business Overview Table 144. Alvogen Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Alvogen Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 146. Alvogen Recent Development Table 147. Alembic Pharmaceuticals Company Information Table 148. Alembic Pharmaceuticals Business Overview Table 149. Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 151. Alembic Pharmaceuticals Recent Development Table 152. Ajanta Pharma Company Information Table 153. Ajanta Pharma Business Overview Table 154. Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 156. Ajanta Pharma Recent Development Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Oseltamivir Phosphate Antiviral Drug Distributors List Table 160. Oseltamivir Phosphate Antiviral Drug Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Oseltamivir Phosphate Antiviral Drug Product Image Figure 2. Global Oseltamivir Phosphate Antiviral Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oseltamivir Phosphate Antiviral Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Oseltamivir Phosphate Antiviral Drug Sales (2021-2032) & (k units) Figure 5. Global Oseltamivir Phosphate Antiviral Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oseltamivir Phosphate Antiviral Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Capsule Image Figure 9. Suspension Image Figure 10. Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Type (2021-2032) Figure 13. Global Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Type (2021-2032) Figure 16. Child Image Figure 17. Aldult Image Figure 18. Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Application (2021-2032) Figure 21. Global Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Application (2021-2032) Figure 24. North America Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2021-2032) Figure 26. U.S. Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2021-2032) Figure 31. Germany Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2021-2032) Figure 38. China Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2021-2032) Figure 46. Brazil Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Oseltamivir Phosphate Antiviral Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Oseltamivir Phosphate Antiviral Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Figure 57. North America Oseltamivir Phosphate Antiviral Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Figure 59. Europe Oseltamivir Phosphate Antiviral Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Oseltamivir Phosphate Antiviral Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Oseltamivir Phosphate Antiviral Drug Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Oseltamivir Phosphate Antiviral Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Suspension
Applications
  • Child
  • Aldult
Companies covered
  • Teva Pharmaceuticals
  • SL Pharmaceutica
  • Cspc Holdings
  • Roche Group
  • Kelun Pharmaceutical
  • HEC ChangJiang Pharmaceutical
  • BrightGene Bio-Medical Technology
  • Zydus Cadila
  • Strides Pharma Inc.
  • Novadoz
  • Natco Pharma
  • Macleods Pharmaceuticals
  • LUPINE Limited
  • Hetero Group
  • Camber Pharmaceuticals
  • Amneal Pharmaceuticals
  • Alvogen
  • Alembic Pharmaceuticals
  • Ajanta Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oseltamivir Phosphate Antiviral Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oseltamivir Phosphate Antiviral Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oseltamivir Phosphate Antiviral Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oseltamivir Phosphate Antiviral Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oseltamivir Phosphate Antiviral Drug Market Dynamics
  1. 2.1 Oseltamivir Phosphate Antiviral Drug Industry Trends
  2. 2.2 Oseltamivir Phosphate Antiviral Drug Industry Drivers
  3. 2.3 Oseltamivir Phosphate Antiviral Drug Industry Opportunities and Challenges
  4. 2.4 Oseltamivir Phosphate Antiviral Drug Industry Restraints
3 Oseltamivir Phosphate Antiviral Drug Market by Manufacturers
  1. 3.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oseltamivir Phosphate Antiviral Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oseltamivir Phosphate Antiviral Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oseltamivir Phosphate Antiviral Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oseltamivir Phosphate Antiviral Drug Manufacturers, Product Type & Application
  7. 3.7 Global Oseltamivir Phosphate Antiviral Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oseltamivir Phosphate Antiviral Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oseltamivir Phosphate Antiviral Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oseltamivir Phosphate Antiviral Drug Tier 1, Tier 2, and Tier 3
4 Oseltamivir Phosphate Antiviral Drug Market by Type
  1. 4.1 Oseltamivir Phosphate Antiviral Drug Type Introduction
  2. 4.1.1 Capsule
  3. 4.1.2 Suspension
  4. 4.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Type
  5. 4.2.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2032)
  7. 4.2.3 Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global Oseltamivir Phosphate Antiviral Drug Revenue by Type
  9. 4.3.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Type (2021-2032)
5 Oseltamivir Phosphate Antiviral Drug Market by Application
  1. 5.1 Oseltamivir Phosphate Antiviral Drug Application Introduction
  2. 5.1.1 Child
  3. 5.1.2 Aldult
  4. 5.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Application
  5. 5.2.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2032)
  7. 5.2.3 Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Application (2021-2032)
  8. 5.3 Global Oseltamivir Phosphate Antiviral Drug Revenue by Application
  9. 5.3.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021-2032)
  11. 5.3.3 Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Application (2021-2032)
6 Global Oseltamivir Phosphate Antiviral Drug Sales by Region
  1. 6.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Oseltamivir Phosphate Antiviral Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oseltamivir Phosphate Antiviral Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oseltamivir Phosphate Antiviral Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oseltamivir Phosphate Antiviral Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oseltamivir Phosphate Antiviral Drug Revenue by Region
  1. 7.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Region
  2. 7.1.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Oseltamivir Phosphate Antiviral Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032)
  8. 7.2.2 North America Oseltamivir Phosphate Antiviral Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032)
  11. 7.3.2 Europe Oseltamivir Phosphate Antiviral Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oseltamivir Phosphate Antiviral Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals
  2. 8.1.1 Teva Pharmaceuticals Company Information
  3. 8.1.2 Teva Pharmaceuticals Business Overview
  4. 8.1.3 Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals Recent Developments
  7. 8.2 SL Pharmaceutica
  8. 8.2.1 SL Pharmaceutica Company Information
  9. 8.2.2 SL Pharmaceutica Business Overview
  10. 8.2.3 SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Product Portfolio
  12. 8.2.5 SL Pharmaceutica Recent Developments
  13. 8.3 Cspc Holdings
  14. 8.3.1 Cspc Holdings Company Information
  15. 8.3.2 Cspc Holdings Business Overview
  16. 8.3.3 Cspc Holdings Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cspc Holdings Oseltamivir Phosphate Antiviral Drug Product Portfolio
  18. 8.3.5 Cspc Holdings Recent Developments
  19. 8.4 Roche Group
  20. 8.4.1 Roche Group Company Information
  21. 8.4.2 Roche Group Business Overview
  22. 8.4.3 Roche Group Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Group Oseltamivir Phosphate Antiviral Drug Product Portfolio
  24. 8.4.5 Roche Group Recent Developments
  25. 8.5 Kelun Pharmaceutical
  26. 8.5.1 Kelun Pharmaceutical Company Information
  27. 8.5.2 Kelun Pharmaceutical Business Overview
  28. 8.5.3 Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio
  30. 8.5.5 Kelun Pharmaceutical Recent Developments
  31. 8.6 HEC ChangJiang Pharmaceutical
  32. 8.6.1 HEC ChangJiang Pharmaceutical Company Information
  33. 8.6.2 HEC ChangJiang Pharmaceutical Business Overview
  34. 8.6.3 HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio
  36. 8.6.5 HEC ChangJiang Pharmaceutical Recent Developments
  37. 8.7 BrightGene Bio-Medical Technology
  38. 8.7.1 BrightGene Bio-Medical Technology Company Information
  39. 8.7.2 BrightGene Bio-Medical Technology Business Overview
  40. 8.7.3 BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Product Portfolio
  42. 8.7.5 BrightGene Bio-Medical Technology Recent Developments
  43. 8.8 Zydus Cadila
  44. 8.8.1 Zydus Cadila Company Information
  45. 8.8.2 Zydus Cadila Business Overview
  46. 8.8.3 Zydus Cadila Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zydus Cadila Oseltamivir Phosphate Antiviral Drug Product Portfolio
  48. 8.8.5 Zydus Cadila Recent Developments
  49. 8.9 Strides Pharma Inc.
  50. 8.9.1 Strides Pharma Inc. Company Information
  51. 8.9.2 Strides Pharma Inc. Business Overview
  52. 8.9.3 Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Product Portfolio
  54. 8.9.5 Strides Pharma Inc. Recent Developments
  55. 8.10 Novadoz
  56. 8.10.1 Novadoz Company Information
  57. 8.10.2 Novadoz Business Overview
  58. 8.10.3 Novadoz Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novadoz Oseltamivir Phosphate Antiviral Drug Product Portfolio
  60. 8.10.5 Novadoz Recent Developments
  61. 8.11 Natco Pharma
  62. 8.11.1 Natco Pharma Company Information
  63. 8.11.2 Natco Pharma Business Overview
  64. 8.11.3 Natco Pharma Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Natco Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio
  66. 8.11.5 Natco Pharma Recent Developments
  67. 8.12 Macleods Pharmaceuticals
  68. 8.12.1 Macleods Pharmaceuticals Company Information
  69. 8.12.2 Macleods Pharmaceuticals Business Overview
  70. 8.12.3 Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  72. 8.12.5 Macleods Pharmaceuticals Recent Developments
  73. 8.13 LUPINE Limited
  74. 8.13.1 LUPINE Limited Company Information
  75. 8.13.2 LUPINE Limited Business Overview
  76. 8.13.3 LUPINE Limited Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 LUPINE Limited Oseltamivir Phosphate Antiviral Drug Product Portfolio
  78. 8.13.5 LUPINE Limited Recent Developments
  79. 8.14 Hetero Group
  80. 8.14.1 Hetero Group Company Information
  81. 8.14.2 Hetero Group Business Overview
  82. 8.14.3 Hetero Group Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hetero Group Oseltamivir Phosphate Antiviral Drug Product Portfolio
  84. 8.14.5 Hetero Group Recent Developments
  85. 8.15 Camber Pharmaceuticals
  86. 8.15.1 Camber Pharmaceuticals Company Information
  87. 8.15.2 Camber Pharmaceuticals Business Overview
  88. 8.15.3 Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  90. 8.15.5 Camber Pharmaceuticals Recent Developments
  91. 8.16 Amneal Pharmaceuticals
  92. 8.16.1 Amneal Pharmaceuticals Company Information
  93. 8.16.2 Amneal Pharmaceuticals Business Overview
  94. 8.16.3 Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  96. 8.16.5 Amneal Pharmaceuticals Recent Developments
  97. 8.17 Alvogen
  98. 8.17.1 Alvogen Company Information
  99. 8.17.2 Alvogen Business Overview
  100. 8.17.3 Alvogen Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Alvogen Oseltamivir Phosphate Antiviral Drug Product Portfolio
  102. 8.17.5 Alvogen Recent Developments
  103. 8.18 Alembic Pharmaceuticals
  104. 8.18.1 Alembic Pharmaceuticals Company Information
  105. 8.18.2 Alembic Pharmaceuticals Business Overview
  106. 8.18.3 Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  108. 8.18.5 Alembic Pharmaceuticals Recent Developments
  109. 8.19 Ajanta Pharma
  110. 8.19.1 Ajanta Pharma Company Information
  111. 8.19.2 Ajanta Pharma Business Overview
  112. 8.19.3 Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio
  114. 8.19.5 Ajanta Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oseltamivir Phosphate Antiviral Drug Value Chain Analysis
  2. 9.1.1 Oseltamivir Phosphate Antiviral Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oseltamivir Phosphate Antiviral Drug Production Mode & Process
  6. 9.2 Oseltamivir Phosphate Antiviral Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oseltamivir Phosphate Antiviral Drug Distributors
  9. 9.2.3 Oseltamivir Phosphate Antiviral Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst